Latest From Intellirod Spine
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced May-June 2015.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June 2015.
Despite contraction in the number of funds and VC firms investing in life sciences, 2013 was a strong year for private investing in medtech, with private investors putting $2.54 million into 129 medical device deals, according to Informa’s Strategic Transactions. Looking at where investors placed their money revealed some emerging trends.
In orthopedics’ next generation, start-ups believe it will be advances in information, gathered by implanted sensors, that will yield the greatest improvements in outcomes, not hardware. We profile OrthoData and Ortho-tag.
- Implantable Devices
- Monitoring Equipment & Devices
- Radiofrequency Devices
- Surgical Equipment & Devices
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- OrthoData Inc.
- North America
- Parent & Subsidiaries
- Intellirod Spine
- Senior Management
- Ric Navarro, Pres. & CEO
- Contact Info
Phone: (234) 678-8965
554F White Pond Dr.
Akron, OH 44320
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.